Search results
Results From The WOW.Com Content Network
Phenytoin (PHT), sold under the brand name Dilantin among others, [1] is an anti-seizure medication. [3] It is useful for the prevention of tonic-clonic seizures (also known as grand mal seizures) and focal seizures, but not absence seizures. [3]
Fetal hydantoin syndrome, also called fetal dilantin syndrome, is a group of defects caused to the developing fetus by exposure to teratogenic effects of phenytoin. Dilantin is the brand name of the drug phenytoin sodium in the United States, commonly used in the treatment of epilepsy .
This is probably a side effect or even the actual mechanism of action for some antiepileptic drugs, since GABA can itself, directly or indirectly, act proconvulsively. [12] Another potential target of antiepileptic drugs is the peroxisome proliferator-activated receptor alpha .
[2]: 118 The rash may also be one of the potentially lethal severe cutaneous adverse reactions, the DRESS syndrome, Stevens–Johnson syndrome, or toxic epidermal necrolysis. [ 3 ] [ 4 ] Systemic manifestations occur at the time of skin manifestations and include a high number of eosinophils in the blood , liver inflammation , and interstitial ...
The LUNSERS is designed to monitor medication-induced side effects. This psychiatric assessment tools allows for the monitoring of side effects related to neuroleptic (or anti-psychotic) medications. The test is a self-reported check-tick box format with a predefined scale from "not at all" to "very much".
Intuniv - an extended release, non-stimulant alpha-2 adrenergic agonist used to treat attention deficit hyperactivity disorder. Available in instant-release under the brand-name Tenex . Invega ( paliperidone ) – atypical antipsychotic used to treat schizophrenia and schizoaffective disorder
Purple glove syndrome (PGS) is a poorly understood skin disease in which the extremities become swollen, discoloured and painful. [1] PGS is potentially serious and may require amputation . PGS is most common among elderly patients and those receiving multiple large intravenous doses of the epilepsy drug phenytoin . [ 2 ]
Fosphenytoin is approved in the United States for the short-term (five days or fewer) treatment of epilepsy when more widely used means of phenytoin administration are not possible or are ill-advised, [4] such as endotracheal intubation, status epilepticus or some other type of repeated seizures; cluster seizure, vomiting, and/or the patient is unalert or not awake or both.